Laurel Wealth Advisors (North Carolina)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,355
Closed -$594K 555
2020
Q1
$594K Buy
3,355
+200
+6% +$37.7K 0.22% 83
2019
Q4
$603K Buy
3,155
+192
+6% +$34.6K 0.19% 94
2019
Q3
$499K Buy
2,963
+785
+36% +$128K 0.17% 103
2019
Q2
$365K Sell
2,178
-140
-6% -$19.4K 0.13% 115
2019
Q1
$339K Sell
2,318
-125
-5% -$18.1K 0.12% 117
2018
Q4
$327K Buy
+2,443
New +$400K 0.13% 111

Other funds holding AGN

Laurel Wealth Advisors (North Carolina)'s AGN Position: Q2 2020 in Review

Laurel Wealth Advisors (North Carolina) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,355 shares — an estimated $594K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $603K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 3,355 Allergan plc shares in Q2 2020, an estimated $594K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Allergan plc position peaked at $603K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q2 2020, filed 6 Aug 2020.